HOOK

In a report released today, Roy Buchanan from JMP Securities reiterated a Buy rating on Hookipa Pharma (HOOK - Research Report), with a price target of $6.00. The company's shares opened today at $1.64.According to TipRanks, Buchanan is an analyst with an average return of -9.7% and a 32.10% success rate. Buchanan covers the Healthcare sector, focusing on stocks such as Enanta Pharmaceuticals, Hookipa Pharma, and PolyPid.Currently, the analyst consensus on Hookipa Pharma is a Strong Buy with an average price target of $6.33, a 285.98% upside from current levels. In a report released on July 27, SVB Securities also maintained a Buy rating on the stock with a $4.
https://www.tipranks.com/news/blurbs/jmp-securities-sticks-to-their-buy-rating-for-hookipa-pharma-hook?utm_source=advfn.com&utm_medium=referral